About: Respiratory Infections

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Respiratory Infections Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Respiratory Infections
Creator	Ginocchio, Christine Ginocchio, C
Source	PMC
abstract	The majority of respiratory tract infections (RTIs) are community acquired and are the single most common cause of physician office visits and among the most common causes of hospitalizations. The morbidity and mortality associated with RTIs are significant and the financial and social burden high due to lost time at work and school. The scope of clinical symptoms can significantly overlap among the respiratory pathogens, and the severity of disease can vary depending on patient age, underlying disease, and immune status, thereby leading to inaccurate presumptions about disease etiology. The rapid and accurate diagnosis of the causative agent of RTIs improves patient care, reduces morbidity and mortality, promotes effective hospital bed utilization and antibiotic stewardship, and reduces length of stay. This chapter focuses on the clinical utility, advantages, and disadvantages of viral and bacterial tests cleared by the Food and Drug Administration (FDA), and new promising technologies for the detection of bacterial agents of pneumonia currently in development or in US FDA clinical trials are briefly reviewed.
has issue date	2015-05-19(xsd:dateTime)
bibo:doi	10.1007/978-3-319-19674-9_52
has license	no-cc
sha1sum (hex)	bdd3a555b2d321c9b2993278c863d229f5141639
schema:url	https://doi.org/10.1007/978-3-319-19674-9_52
resource representing a document's title	Respiratory Infections
has PubMed Central identifier	PMC7123443
schema:publication	Molecular Pathology in Clinical Practice
resource representing a document's body	covid:bdd3a555b2d321c9b2993278c863d229f5141639#body_text
is schema:about of	named entity 'HOSPITAL' named entity 'TESTS' named entity '80%' named entity 'bacterial' named entity 'immune' named entity 'respiratory' named entity 'LOWER RESPIRATORY TRACT INFECTIONS' named entity 'RESPIRATORY INFECTIONS' named entity 'IMPROVES' named entity 'AT WORK' named entity 'CHAPTER' named entity 'DIAGNOSIS' named entity 'INACCURATE' named entity 'TESTS' named entity 'UNDERLYING' named entity 'COMMON' named entity 'PATIENT AGE' named entity 'BURDEN' named entity 'HOSPITAL BED' named entity 'CANT' named entity 'CURRENTLY' named entity 'ACCURATE' named entity 'SEVERITY' named entity 'CLEARED BY' named entity 'PNEUMONIA' named entity 'FOOD AND DRUG ADMINISTRATION' named entity 'SOCIAL' named entity 'MAJORITY' named entity 'PATIENT CARE' covid:arg/bdd3a555b2d321c9b2993278c863d229f5141639 named entity 'CAUSATIVE AGENT' named entity 'SINGLE' named entity 'HIGH' named entity 'BACTERIAL' named entity 'DISEASE' named entity 'RESPIRATORY PATHOGENS' named entity 'TECHNOLOGIES' named entity 'EFFECTIVE' named entity 'ANTIBIOTIC' named entity 'CLINICAL UTILITY' named entity 'DUE TO' named entity 'ASSOCIATED WITH' named entity 'LEADING' named entity 'STEWARDSHIP' named entity 'UTILIZATION' named entity 'VISITS' named entity 'COMMUNITY ACQUIRED' named entity 'HOSPITALIZATIONS' named entity 'MOLECULAR' named entity 'MORBIDITY AND MORTALITY' named entity 'UPPER RESPIRATORY TRACT INFECTIONS' named entity 'COMMUNITY-ACQUIRED PNEUMONIA' named entity 'RESPIRATORY PATHOGENS' named entity 'ACQUIRED' named entity 'PNEUMONIA' named entity 'DETECTION' named entity 'CAUSES' named entity 'RAPID' named entity 'REVIEWED' named entity 'CLINICAL TRIALS' named entity 'DEVELOPMENT' named entity 'OVERLAP' named entity 'PHYSICIAN' named entity 'TIME' named entity 'RESPIRATORY TRACT INFECTIONS' named entity 'NEW' named entity 'LOST' named entity 'CAUSE' named entity 'LENGTH OF STAY' named entity 'VIRAL' named entity 'BACTERIAL' named entity 'SCHOOL' named entity 'VIRAL AND' named entity 'SCOPE' named entity 'IMMUNE STATUS' named entity 'ABOUT' named entity 'FDA' named entity 'CLINICAL SYMPTOMS' named entity 'acquired' named entity 'utilization' named entity 'patient' named entity 'advantages'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software